LivaNova: First Patient Implanted in Aura6000 Neurostimulator Study
The randomized controlled trial seeks to demonstrate the safety and effectiveness of the LivaNova aura6000 System for moderate to severe OSA.
Read MoreThe randomized controlled trial seeks to demonstrate the safety and effectiveness of the LivaNova aura6000 System for moderate to severe OSA.
Read MoreThe new HCPCS code for Somryst encompasses “Prescription Digital Behavioral Therapy, FDA Cleared, per Course of Treatment.”
Read MoreTo better promote healing, hospitals are starting to take steps to encourage inpatients to get enough slumber during their stays.
Read MoreThe CMS coding decision was published on February 16, 2022, and the following codes will become effective on April 1, 2022.
Read MoreWe have thoughts, visions and feelings while we sleep, experiencing a virtual reality of sorts. But how and why does dreaming happen?
Read More